1. Home
  2. TXG vs USPH Comparison

TXG vs USPH Comparison

Compare TXG & USPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • USPH
  • Stock Information
  • Founded
  • TXG 2012
  • USPH 1990
  • Country
  • TXG United States
  • USPH United States
  • Employees
  • TXG N/A
  • USPH N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • USPH Medical/Nursing Services
  • Sector
  • TXG Industrials
  • USPH Health Care
  • Exchange
  • TXG Nasdaq
  • USPH Nasdaq
  • Market Cap
  • TXG 1.6B
  • USPH 1.4B
  • IPO Year
  • TXG 2019
  • USPH 1992
  • Fundamental
  • Price
  • TXG $13.32
  • USPH $91.16
  • Analyst Decision
  • TXG Buy
  • USPH Strong Buy
  • Analyst Count
  • TXG 12
  • USPH 5
  • Target Price
  • TXG $13.54
  • USPH $110.20
  • AVG Volume (30 Days)
  • TXG 2.8M
  • USPH 151.8K
  • Earning Date
  • TXG 11-06-2025
  • USPH 11-05-2025
  • Dividend Yield
  • TXG N/A
  • USPH 1.98%
  • EPS Growth
  • TXG N/A
  • USPH 116.39
  • EPS
  • TXG N/A
  • USPH 2.29
  • Revenue
  • TXG $644,466,000.00
  • USPH $722,201,000.00
  • Revenue This Year
  • TXG $2.11
  • USPH $18.73
  • Revenue Next Year
  • TXG N/A
  • USPH $6.13
  • P/E Ratio
  • TXG N/A
  • USPH $39.85
  • Revenue Growth
  • TXG 2.02
  • USPH 16.25
  • 52 Week Low
  • TXG $6.78
  • USPH $62.77
  • 52 Week High
  • TXG $18.21
  • USPH $101.20
  • Technical
  • Relative Strength Index (RSI)
  • TXG 57.51
  • USPH 62.82
  • Support Level
  • TXG $12.08
  • USPH $86.10
  • Resistance Level
  • TXG $13.45
  • USPH $90.92
  • Average True Range (ATR)
  • TXG 0.76
  • USPH 2.73
  • MACD
  • TXG 0.18
  • USPH -0.03
  • Stochastic Oscillator
  • TXG 95.82
  • USPH 79.17

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About USPH U.S. Physical Therapy Inc.

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

Share on Social Networks: